help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on December 10, 2004, doi:10.1164/rccm.200408-1088OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200408-1088OCv2
171/6/587    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teper, A. M.
Right arrow Articles by Maffey, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teper, A. M.
Right arrow Articles by Maffey, A. F.
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 587-590, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200408-1088OC

Original Article

Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma

Alejandro M. Teper, Carlos D. Kofman, Gabriela A. Szulman, Santiago M. Vidaurreta and Alberto F. Maffey

Respiratory Center, "Ricardo Gutierrez" Children's Hospital, Buenos Aires, Argentina

Correspondence and requests for reprints should be addressed to Alejandro M. Teper, M.D., Respiratory Center, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, Buenos Aires, Argentina. E-mail: ateper{at}intramed.net

This study assessed the effects of treatment with fluticasone in children younger than 2 years old with recurrent wheezing and risk factors of developing asthma. This double-blind placebo-controlled study randomized children to receive fluticasone (125 µg; n = 14) or placebo (n = 12) twice daily for 6 months. Pulmonary function was assessed at the beginning and end, and parents filled out a daily diary recording respiratory symptoms, need for rescue medication, and emergency care. The SD score of maximum flow at functional residual capacity was –0.74 ± 0.6 at the beginning and 0.44 ± 1 at the end for the fluticasone group (p = 0.001), and –0.79 ± 0.3 at the beginning and –0.78 ± 1.4 at the end for the placebo group (p = 0.97). A statistically significant difference (p = 0.02) was observed between treatments. The percentage of symptom-free days was 91.3 ± 7% for fluticasone and 83.9 ± 10% for placebo (p = 0.05). The number of respiratory exacerbations was 2.1 ± 1.7 and 4.1 ± 3 (p = 0.04), and the percentage of days on albuterol was 8.6 ± 6% and 16.3 ± 9% (p = 0.028). Treatment with fluticasone twice daily for 6 months improves pulmonary function and clinical outcomes in children with asthma younger than 2 years.

Key Words: asthma • infants • inhaled corticosteroids • pulmonary function




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
A S Pelkonen, K Malmstrom, L P Malmberg, S Sarna, M Turpeinen, M Kajosaari, T Haahtela, and M J Makela
Budesonide improves decreased airway conductance in infants with respiratory symptoms
Arch. Dis. Child., July 1, 2009; 94(7): 536 - 541.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. A. Castro-Rodriguez and G. J. Rodrigo
Efficacy of Inhaled Corticosteroids in Infants and Preschoolers With Recurrent Wheezing and Asthma: A Systematic Review With Meta-analysis
Pediatrics, March 1, 2009; 123(3): e519 - e525.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. L. P. Brand, E. Baraldi, H. Bisgaard, A. L. Boner, J. A. Castro-Rodriguez, A. Custovic, J. de Blic, J. C. de Jongste, E. Eber, M. L. Everard, et al.
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
Eur. Respir. J., October 1, 2008; 32(4): 1096 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
H. Eigen
Differential Diagnosis and Treatment of Wheezing and Asthma in Young Children
Clinical Pediatrics, October 1, 2008; 47(8): 735 - 743.
[PDF]

Home page
 CLIN PEDIATRHome page
M. J. Welch
Nebulization Therapy for Asthma: A Practical Guide for the Busy Pediatrician
Clinical Pediatrics, October 1, 2008; 47(8): 744 - 756.
[PDF]

Home page
 EDUCATION AND PRACTICEHome page
J H Baumer
Recent asthma updates in the USA and UK
Arch. Dis. Child. Ed. Pract., April 1, 2008; 93(2): 66 - 68.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. C. Moore and S. P. Peters
Update in Asthma 2006
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 649 - 654.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706.
[Full Text] [PDF]

Home page
 PediatricsHome page
S. P. Galant, T. Morphew, S. Amaro, and O. Liao
Current Asthma Guidelines May Not Identify Young Children Who Have Experienced Significant Morbidity
Pediatrics, April 1, 2006; 117(4): 1038 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. F. M. Merkus and J. C. de Jongste
Inhaled Corticosteroids in Wheezy Infants
Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 1058 - 1059.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. M. Teper, C. D. Kofman, and S. M. Vidaurreta
Inhaled Corticosteroids in Wheezy Infants
Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 1059 - 1059.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  Red In Translatin